Compare PBH & QTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBH | QTWO |
|---|---|---|
| Founded | 1996 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 2004 | 2014 |
| Metric | PBH | QTWO |
|---|---|---|
| Price | $47.72 | $46.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $75.33 | ★ $82.64 |
| AVG Volume (30 Days) | 714.8K | ★ 949.4K |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 225.00 |
| EPS | ★ 3.91 | 0.40 |
| Revenue | ★ $975,777,000.00 | $193,978,000.00 |
| Revenue This Year | N/A | $12.48 |
| Revenue Next Year | $4.31 | $10.18 |
| P/E Ratio | ★ $17.31 | $115.44 |
| Revenue Growth | ★ 36.77 | N/A |
| 52 Week Low | $42.62 | $44.46 |
| 52 Week High | $87.09 | $95.10 |
| Indicator | PBH | QTWO |
|---|---|---|
| Relative Strength Index (RSI) | 33.79 | 42.43 |
| Support Level | $42.62 | $45.33 |
| Resistance Level | $62.91 | $53.15 |
| Average True Range (ATR) | 2.39 | 2.03 |
| MACD | -0.27 | -0.25 |
| Stochastic Oscillator | 36.55 | 18.26 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Q2 Holdings Inc provides digital solutions to financial institutions, financial technology companies, and alternative finance companies, seeking to incorporate banking into their customer engagement and servicing strategies. The company helps its clients with supervisory, consumer protection, privacy, third-party risk management requirements, and cyber threats and fraud, among other applications, by offering a portfolio of digital solutions, which comprises its digital banking offerings, digital lending and relationship pricing solutions, risk and fraud solutions, as well as Q2 Innovation Studio and Helix. Q2 derives the majority of its revenue from subscription fees for the use of its hosted solutions.